|
Study site
|
Year
|
Village
|
Time relative to MDA (week)
|
|---|
| | | |
Week -3
|
Week -2
|
Week -1
|
Week 1
|
Week 2
|
Week 3
|
|---|
|
Burkina Faso
|
2013 (Aug.-Sept.)
|
Control
|
0.96 ± 0.02 (89)
|
0.70 ± 0.05 (70)
|
NA
|
0.71 ± 0.03 (266)
|
0.651 ± 0.04 (129)
|
0.89 ± 0.05 (45)
|
|
Treated
|
0.85 ± 0.04 (75)
|
0.75 ± 0.04 (122)
|
NA
|
0.50 ± 0.03 (329)
|
0.709 ± 0.03 (196)
|
0.81 ± 0.06 (41)
|
|
p-value
|
0.0477
|
0.6029
|
-
|
1.54E-07
|
0.3268
|
0.4325
|
|
Liberia
|
2013 (June)
|
Control
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
|
Treated
|
NA
|
0.98 ± 0.01 (104)
|
0.91 ± 0.04 (66)
|
0.42 ± 0.04 (147)
|
0.86 ± 0.05 (50)
|
NA
|
|
p-value
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Senegal
|
2009 (Oct.)
|
Control
|
NA
|
NA
|
0.83 ± 0.06 (40)
|
0.81 ± 0.05 (62)
|
0.792 ± 0.08 (24)
|
NA
|
|
Treated
|
NA
|
NA
|
0.79 ± 0.02 (338)
|
0.48 ± 0.04 (168)
|
0.75 ± 0.06 (48)
|
NA
|
|
p-value
|
-
|
-
|
0.7879
|
1.5E-05
|
0.9218
|
-
|
|
2009 (July-Aug.)
|
Control
|
NA
|
0.77 ± 0.08 (26)
|
0.61 ± 0.09 (33)
|
0.72 ± 0.06 (60)
|
0.833 ± 0.07 (30)
|
NA
|
|
Treated
|
NA
|
0.90 ± 0.04 (59)
|
0.82 ± 0.03 (154)
|
0.57 ± 0.04 (150)
|
0.819 ± 0.03 (160)
|
NA
|
|
p-value
|
-
|
0.2162
|
0.015
|
0.077
|
1
|
-
|
|
2008 (Aug.)
|
Control
|
NA
|
NA
|
0.76 ± 0.07 (37)
|
1.0 ± 0 (26)
|
0.842 ± 0.08 (19)
|
NA
|
|
Treated
|
NA
|
NA
|
0.70 ± 0.05 (89)
|
0.40 ± 0.06 (70)
|
0.636 ± 0.15 (11)
|
NA
|
| | |
p-value
|
-
|
-
|
0.6427
|
4.78E-07
|
0.4031
|
-
|
- Data presented are mean survival rate ± s.e. with sample size in brackets. Significance of differences (p-value) between the control and the treated villages were assessed using χ2 test, p-value below 0.05 are indicated in bold.
